Leukemic stem cells and measurable residual disease in AML: An emerging new outcome parameter

Research output: ThesisResearch VU University Amsterdam, graduation VU University Amsterdam

Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • VU Vrije Universiteit
Supervisors/Advisors
  • Ossenkoppele, Gert, Supervisor
  • Schuurhuis, Gerrit, Co-supervisor
Award date22 Nov 2017
Publication statusPublished - 2017

Cite this